After chemo and the mabs, is regorafenib the treatment for mCRC? If so, a trial pairing leronlimab with regorafenib that shows noticeably better results than what reforafenib has shown alone might lead to an accelerated approval.

Do we know how Cytodyn was planning to get regorafenib for this trial? Did they have a collaboration with Bayer?